Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Schizophrenia
In brief
Study to evaluate the safety and efficacy of luvadaxistat compared with placebo on improving cognitive performance in participants with schizophrenia.
Key facts
- Study ID
- NCT05182476
- Run by
- Neurocrine Biosciences
- People needed
- 216
- Starts
- 2021-12-07
- Expected to finish
- 2024-10-14
- Last updated by the study team
- 2025-07-02
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Neurocrine Clinical Site — Phoenix, Arizona, United States
- Neurocrine Clinical Site — Bentonville, Arkansas, United States
- Neurocrine Clinical Site — Bryant, Arkansas, United States
- Neurocrine Clinical Site — Anaheim, California, United States
- Neurocrine Clinical Site — Bellflower, California, United States
- Neurocrine Clinical Site — Garden Grove, California, United States
- Neurocrine Clinical Site — Glendale, California, United States
- Neurocrine Clinical Site — Oceanside, California, United States
- Neurocrine Clinical Site — Pico Rivera, California, United States
- Neurocrine Clinical Site — San Diego, California, United States
- Neurocrine Clinical Site — San Diego, California, United States
- Neurocrine Clinical Site — San Rafael, California, United States
- Neurocrine Clinical Site — Stanford, California, United States
- Neurocrine Clinical Site — Torrance, California, United States
- Neurocrine Clinical Site — Aventura, Florida, United States
- Neurocrine Clinical Site — Miami, Florida, United States
- Neurocrine Clinical Site — Miami, Florida, United States
- Neurocrine Clinical Site — Miami, Florida, United States
- Neurocrine Clinical Site — Miami, Florida, United States
- Neurocrine Clinical Site — Okeechobee, Florida, United States
- Neurocrine Clinical Site — Pensacola, Florida, United States
- Neurocrine Clinical Site — Tampa, Florida, United States
- Neurocrine Clinical Site — Atlanta, Georgia, United States
- Neurocrine Clinical Site — Chicago, Illinois, United States
- Neurocrine Clinical Site — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.